Adjuvant erythropoietin therapy does not improve survival in newborns with hypoxic-ischemic encephalopathy
1. Erythropoietin administration did not lower the risk of death or neurodevelopmental impairment in newborns with hypoxic-ischemic encephalopathy as compared ...
